Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Pembrolizumab and Bevacizumab in Treating Patients with Metastatic Melanoma or Non-small Cell Lung Cancer with Untreated Brain Metastases

Trial Status: complete

This phase II trial studies how well pembrolizumab and bevacizumab work in treating patients with melanoma that has spread to the other parts of the body or non-small cell lung cancer that has spread to the brain. Immunotherapy with monoclonal antibodies, such as pembrolizumab and bevacizumab, may help the body’s immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.